Prize pHight: who says the natural products industry should decry drugs with OTC status? The opportunity for exploiting underappreciated weaknesses in ... An article from: Nutraceuticals World
Book Details
Author(s)Anthony Almada
PublisherRodman Publishing
ISBN / ASINB001JTZPQU
ISBN-13978B001JTZPQ1
AvailabilityAvailable for download now
Sales Rank99,999,999
MarketplaceUnited States 🇺🇸
Description
This digital document is an article from Nutraceuticals World, published by Rodman Publishing on March 1, 2008. The length of the article is 843 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.
Citation Details
Title: Prize pHight: who says the natural products industry should decry drugs with OTC status? The opportunity for exploiting underappreciated weaknesses in the digestive health category, au naturel, is explosive.(PROPRIETARY PERSPECTIVES)
Author: Anthony Almada
Publication:Nutraceuticals World (Magazine/Journal)
Date: March 1, 2008
Publisher: Rodman Publishing
Volume: 11 Issue: 3 Page: 28(2)
Distributed by Gale, a part of Cengage Learning
Citation Details
Title: Prize pHight: who says the natural products industry should decry drugs with OTC status? The opportunity for exploiting underappreciated weaknesses in the digestive health category, au naturel, is explosive.(PROPRIETARY PERSPECTIVES)
Author: Anthony Almada
Publication:Nutraceuticals World (Magazine/Journal)
Date: March 1, 2008
Publisher: Rodman Publishing
Volume: 11 Issue: 3 Page: 28(2)
Distributed by Gale, a part of Cengage Learning

